Chronic Kidney Disease News

SAN DIEGO — In this video exclusive from ASN Kidney Week, Darcy K. Weidemann, MD, MHS, FAAP, a pediatric nephrologist at Children’s Mercy in Kansas City, Missouri, discusses her top concerns in the specialty: access and workforce.

SAN DIEGO — Help with transportation, copays and treatment adherence were the top three needs affecting health care according to a group of patients participating in a lupus navigator pilot program.

SAN DIEGO — Genetic evaluation of patients referred to a U.S. glomerular disease center revealed a genetic diagnosis in 35% of cases, informing prognosis and treatment and allowing for family testing, among other benefits.

The FDA has granted rare pediatric disease designation to Omeros Corporation’s zaltenibart for the treatment of complement 3 glomerulopathy, according to a press release.

SAN DIEGO — Access to home dialysis among patients with disabilities with end-stage kidney disease decreased during the COVID-19 pandemic, according to data presented here at ASN Kidney Week.

In these videos, Koyal Jain, MD, MPH, FASN, associate professor of medicine and director, nephrology and hypertension training program at UNC School of Medicin, discusses the latest advancements in glomerular diseases.

SAN DIEGO — In this video exclusive from ASN Kidney Week, Jeffrey Giullian, MD, MBA, FASN, chief medical officer of DaVita, discusses three pressing regulatory issues for nephrology stakeholders.

Early treatment with mycophenolate mofetil can reduce subsequent risks for severe flares and lupus nephritis in newly diagnosed systemic lupus erythematosus, according to data published in JAMA Network Open.

Prescriptions for GLP-1 receptor agonists and SGLT2 inhibitors for patients with type 1 diabetes rose between 2010 and 2023 despite not being approved for that population, according to a research letter published in JAMA.

Reaching an appropriate blood pressure target is key to lowering risks for cardiorenal complications, but many patients with chronic kidney disease may be unable to do so, prospective study data show.